Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55

Immunology

Volumn 101, Issue 1, 2000, Pages 154-160

  Neidleman, J A ^a   Vajdy, M ^a   Ugozzoli, M ^a   Ott, G ^a   O'Hagan, D ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI ENTEROTOXIN; GAG PROTEIN; IMMUNOLOGICAL ADJUVANT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; ESCHERICHIA COLI; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; AIDS VACCINES; ANIMALS; BACTERIAL TOXINS; CELL CULTURE TECHNIQUES; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; GENE PRODUCTS, GAG; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MUTAGENESIS, SITE-DIRECTED; PROTEIN PRECURSORS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033797049     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00090.x     Document Type: Article

References (26)

1. Localization of simian immunodefeciency virus-infected cells in the genital tract of male and female Rhesus macaques
2. + T cells, and AIDS
3. Use of Escherichia coli heat-labile enterotoxin as an oral adjuvant
4. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
5. A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit
6. The adjuvant effect of a non-toxic mutant heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide
7. Isolation and characterization of homogeneous heat-labile enterotoxin with high specific activity from Escherichia coli cultures
8. Properties of homogeneous heat-labile enterotoxin from Escherichia coli
9. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis
10. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity
11. The T cell repertoire primed by antiviral vaccination is influenced by self-tolerance
12. HIV-1 p24 gag-specific cytotoxic T-lymphocyte responses in mice
13. A quantitative assay of peptide-dependant class I assembly
14. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO-derived gp120 is enhanced by enzymatic removal of N-linked glycans
15. + T cell depletion and enteropathy in simian immunodefeciency virus-infected rhesus macaques
16. + T cell depletion and viral replication in SIV infection
17. MHC class-I restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
18. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: Differential effects of the nontoxic AB complex and enzyme activity on TH1 and TH2 cells
19. Lymphocyte homing and intestinal immunity
20. Functional role of mucosal cytotoxic lymphocytes
21. Mucosal delivery of herpes simplex vaccine
22. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant
23. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus
24. Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodefeciency virus gp160 in mice: Induction of serum, intestinal, vaginal, and lung IgA and IgG
25. HIV-1 neutralizing antibodies in the genital and respiratory tract of intranasally immunized with oligomeric gp160
26. Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization